Virtu Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $220K | Sell |
2,071
-7,291
| -78% | -$775K | 0.01% | 884 |
|
2025
Q1 | $1.16M | Buy |
+9,362
| New | +$1.16M | 0.06% | 234 |
|
2024
Q2 | – | Sell |
-11,696
| Closed | -$1.41M | – | 1590 |
|
2024
Q1 | $1.41M | Buy |
11,696
+2,819
| +32% | +$339K | 0.11% | 158 |
|
2023
Q4 | $1.09M | Buy |
8,877
+4,538
| +105% | +$558K | 0.09% | 186 |
|
2023
Q3 | $562K | Buy |
+4,339
| New | +$562K | 0.06% | 306 |
|
2022
Q4 | – | Sell |
-8,306
| Closed | -$1.11M | – | 1887 |
|
2022
Q3 | $1.11M | Buy |
+8,306
| New | +$1.11M | 0.1% | 175 |
|
2022
Q2 | – | Sell |
-1,480
| Closed | -$230K | – | 1811 |
|
2022
Q1 | $230K | Sell |
1,480
-232
| -14% | -$36.1K | 0.02% | 710 |
|
2021
Q4 | $218K | Buy |
+1,712
| New | +$218K | 0.02% | 798 |
|
2021
Q2 | – | Sell |
-3,318
| Closed | -$545K | – | 1779 |
|
2021
Q1 | $545K | Buy |
+3,318
| New | +$545K | 0.04% | 483 |
|
2019
Q1 | – | Sell |
-2,074
| Closed | -$257K | – | 1624 |
|
2018
Q4 | $257K | Sell |
2,074
-2,523
| -55% | -$313K | 0.01% | 785 |
|
2018
Q3 | $773K | Buy |
+4,597
| New | +$773K | 0.05% | 415 |
|
2018
Q2 | – | Sell |
-3,097
| Closed | -$468K | – | 2241 |
|
2018
Q1 | $468K | Sell |
3,097
-99
| -3% | -$15K | 0.03% | 734 |
|
2017
Q4 | $430K | Sell |
3,196
-760
| -19% | -$102K | 0.02% | 951 |
|
2017
Q3 | $578K | Buy |
+3,956
| New | +$578K | 0.03% | 804 |
|